Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SUTRO BIOPHARMA, INC.

(STRO)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 01-12-2022
7.420 USD   -0.93%
09/11Transcript : Sutro Biopharma, Inc. Presents at Credit Suisse 31st Annual Healthcare Conference, Nov-09-2022 08:35 AM
CI
09/11Sutro Biopharma, Inc. : HC Wainwright geeft koopadvies
MM
08/11Sutro Biopharma, Inc. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op SUTRO BIOPHARMA, INC.ETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
IQ Chaikin U.S. Small Cap ETF - USD0.16%0.73%VS
IShares Micro-Cap ETF - USD0.06%0.63%VS
IShares Nasdaq US Biotechnology (D) - USD0.03%2.62%VS
IShares Nasdaq US Biotechnology - USD0.03%2.78%VS
Invesco Nasdaq Biotechnology ETF - USD0.03%2.39%-VS
Vanguard Russell 2000 Value ETF - USD0.02%0.98%VS
IShares Biotechnology ETF - USD0.02%2.70%-NC
IShares Russell 2000 Value ETF - USD0.02%1.18%VS
Invesco FTSE RAFI US 1500 Small-Mid ETF - USD0.01%0.98%VS
Xtrackers Russell 2000 1C - USD0.01%0.02%VS
Vanguard Russell 2000 ETF - USD0.01%1.11%VS
IShares Russell 2000 ETF - USD0.01%-1.27%VS



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek SUTRO BIOPHARMA, INC.
Duur : Periode :
Sutro Biopharma, Inc. : Grafische technische analyse Sutro Biopharma, Inc. | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Kopen
Aantal analisten 9
Laatste slotkoers 7,49 $
Gemiddelde koersdoel 21,38 $
Spread / Gemiddelde doel 185%
Grafiek SUTRO BIOPHARMA, INC.
Duur : Periode :
Sutro Biopharma, Inc. : Grafische technische analyse Sutro Biopharma, Inc. | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
SUTRO BIOPHARMA, INC.-50.13%430
VERTEX PHARMACEUTICALS46.07%81 217
REGENERON PHARMACEUTICALS, INC.19.03%80 283
BIONTECH SE-34.26%40 589
WUXI APPTEC CO., LTD.-34.22%32 137
GENMAB A/S25.29%29 594